Literature DB >> 10225436

Dr. Josef Steiner Cancer Research Prize Lecture: the role of physiological cell death in neoplastic transformation and in anti-cancer therapy.

A Strasser1.   

Abstract

Cell death is a physiological process which is required for normal development and existence of multi-cellular organisms. Physiological cell death, or apoptosis, is controlled by an evolutionarily conserved mechanism. Abnormalities in this process are implicated as a cause or contributing factor in a variety of diseases. Inhibition of apoptosis can promote neoplastic transformation, particularly in combination with dysregulated cell-cycle control, and can influence the response of tumour cells to anti-cancer therapy. Molecular biological and biochemical approaches are used to find missing cell-death regulators and to define signalling cascades, while experiments in genetically modified mice will identify the essential function of these molecules. Discoveries from cell death research should provide clues for designing therapies for a variety of diseases, including degenerative disorders, auto-immunity and cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225436     DOI: 10.1002/(sici)1097-0215(19990517)81:4<505::aid-ijc1>3.0.co;2-j

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection.

Authors:  Andrea Albinger-Hegyi; Bernhard Hochreutener; Marie-Therese Abdou; Ivan Hegyi; María Teresa Dours-Zimmermann; Michael O Kurrer; Philipp U Heitz; Dieter R Zimmermann
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells.

Authors:  Feifan Zhou; Da Xing; Wei R Chen
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

Review 3.  Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy.

Authors:  J Gómez-Navarro; W Arafat; J Xiang
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.